Published: 14 March 2019
Author(s): Christina Tiller, Martin Reindl, Magdalena Holzknecht, Maximilian Klapfer, Alexander Beck, Benjamin Henninger, Agnes Mayr, Gert Klug, Sebastian Johannes Reinstadler, Bernhard Metzler
Issue: March 2019

High-sensitivity cardiac troponin T (hs-cTnT) represents the biomarker of choice for infarct size (IS) estimation in patients with acute ST-elevation myocardial infarction (STEMI). However, admission values of hs-cTnT are only weakly associated with IS. The aim of this study was to investigate the incremental value of different biomarkers measured on admission for IS estimation in STEMI patients.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.